6/30 2021

5G revolution drives job growth

2021-07-02T15:19:34+00:00June 30th, 2021|Success Stories|

The National Spectrum Consortium recently teamed up with the Progressive Policy Institute (PPI) to research the impact of the 5G revolution to create millions of jobs over the next 15 years. The research paper reviewed three time periods of wireless-driven job growth in the U.S., and reviews job creation, industries affected, and job location.

6/23 2021

NSTIC celebrates two years of supporting naval surface technology innovation

2021-07-06T12:28:09+00:00June 23rd, 2021|Success Stories|

This June, the Navy Surface Technology and Innovation Consortium (NSTIC) celebrates two years of supporting the Navy by providing access to innovative technologies that address current and future threats in the surface and maritime environment.

6/15 2021

UTIC members: Strong resource for innovative undersea and maritime technology

2021-07-07T19:33:05+00:00June 15th, 2021|Success Stories|

The Undersea Technology Innovation Consortium (UTIC) is celebrating three years of supporting the Navy this June. UTIC has built a national community to advance and accelerate undersea and maritime technology innovation.

6/4 2021

MCDC member receives DoD funding for Phase-2 trials of PUL-042 against COVID-19

2021-09-22T12:31:04+00:00June 4th, 2021|Success Stories|

Pulmotect, Inc., a clinical-stage biotechnology company and non-traditional Medical CBRN Defense Consortium (MCDC) member, is joining the fight against COVID-19.

5/26 2021

MTEC member researches treatment of septic shock, the cause of 70% of COVID deaths

2021-07-07T19:50:26+00:00May 26th, 2021|Success Stories|

Vivacelle Bio, Inc., a non-traditional small business and Medical Technology Enterprise Consortium (MTEC) member, was awarded $5.3 million to research treatment of septic shock.

5/20 2021

MTEC member developing novel engineered antibody that neutralizes coronaviruses

2021-07-07T19:57:53+00:00May 20th, 2021|Success Stories|

With funding from the Medical Technology Enterprise Consortium (MTEC), Centivax is developing an optimized antibody therapeutic to treat, as well as protect against, COVID-19.

Go to Top